<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Foster Bossen | Activity</title>
	<link>https://www.catswannabecats.com/members/rundollar16/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/rundollar16/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Foster Bossen.</description>
	<lastBuildDate>Sat, 04 Jul 2026 08:03:39 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">5a0960b8e0ea02f2ae28985fafa2bd83</guid>
				<title>Foster Bossen posted an update: Whilst the survival rates of childhood acute lymphoblastic [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/11232/</link>
				<pubDate>Sun, 01 Jun 2025 05:21:33 -0400</pubDate>

									<content:encoded><![CDATA[<p>Whilst the survival rates of childhood acute lymphoblastic leukemia (ALL) have increased remarkably over the last decades, the therapy resistance and toxicity are still the major causes of treatment failure. It was shown that overexpression of heme oxygenase-1 (HO-1) promotes proliferation and chemoresistance of cancer cells. In humans, the HO-1&hellip;<span class="activity-read-more" id="activity-read-more-11232"><a href="https://www.catswannabecats.com/activity/p/11232/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">98cd3731cb0762dd2d573065fa06f008</guid>
				<title>Foster Bossen became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/10326/</link>
				<pubDate>Sun, 01 Jun 2025 00:22:19 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>